These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7209982)

  • 21. The toxicity of the radiosensitizer misonidazole towards hypoxic cells in vitro: a model for mouse and man.
    Stratford IJ; Adams GE
    Br J Radiol; 1978 Sep; 51(609):745-6. PubMed ID: 698523
    [No Abstract]   [Full Text] [Related]  

  • 22. Enhancement of artificial lung metastases by misonidazole.
    Rockwell S; Nierenburg M; Irvin CG
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1395-8. PubMed ID: 6469763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Misonidazole enhancement of acute and late radiation injury to the rat spinal cord.
    Yuhas JM
    Br J Cancer; 1979 Jul; 40(1):161-3. PubMed ID: 454561
    [No Abstract]   [Full Text] [Related]  

  • 24. Teratogenic and radiosensitizing effects of misonidazole on mouse embryos.
    Michel C; Fritz-Niggli H
    Br J Radiol; 1981 Feb; 54(638):154-5. PubMed ID: 7193062
    [No Abstract]   [Full Text] [Related]  

  • 25. Combined effects of misonidazole radiosensitization and hypoxic cell toxicity in mammalian cells.
    Michaels HB; Peterson EC; Ling CC; Epp ER
    Radiat Res; 1981 Nov; 88(2):354-68. PubMed ID: 7302141
    [No Abstract]   [Full Text] [Related]  

  • 26. A biochemical assessment of the neurotoxicity of the radiosensitizing drug misonidazole in the rat.
    Rose GP; Dewar AJ; Moffett BJ; Stratford IJ
    Clin Toxicol; 1981 Dec; 18(12):1411-26. PubMed ID: 6277552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A phase I study of misonidazole and pelvic irradiation in patients with carcinoma of cervix.
    Thomas GM; Rauth AM; Black BE; Cummings BJ; Sorenti VL; Bush RS
    Br J Cancer; 1982 Jun; 45(6):860-8. PubMed ID: 6284190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of oxygen on misonidazole chemosensitization and cytotoxicity in vitro.
    Mulcahy RT
    Cancer Res; 1984 Oct; 44(10):4409-13. PubMed ID: 6467202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Split dose cytotoxic experiments with misonidazole.
    Stratford IJ
    Br J Cancer; 1978 Jul; 38(1):130-6. PubMed ID: 687510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on the toxicity and radiosensitizing ability of misonidazole under conditions of prolonged incubation.
    Wong TW; Whitmore GF; Gulyas S
    Radiat Res; 1978 Sep; 75(3):541-55. PubMed ID: 724984
    [No Abstract]   [Full Text] [Related]  

  • 31. Modification of the action of misonidazole. I. Effect of TAN on toxicity.
    Skov KA; Palcic B; Harrison IE; Skarsgard LD
    Int J Radiat Biol Relat Stud Phys Chem Med; 1980 Jun; 37(6):601-11. PubMed ID: 6968295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncogenic transformation in vitro by the hypoxic cell sensitizer misonidazole.
    Miller RC; Hall EJ
    Br J Cancer; 1978 Sep; 38(3):411-7. PubMed ID: 708572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Misonidazole enhances cyclophosphamide toxicity to bone marrow.
    Allalunis MJ; Turner AR; Chapman JD
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):655-8. PubMed ID: 7107393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on the protection against misonidazole-induced toxicity by antiinflammatory agents.
    Millar BC; Chaplin DJ; Jinks S
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():303-8. PubMed ID: 6221607
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of acute and chronic misonidazole administration on peripheral-nerve electrophysiology in mice.
    Conroy PJ; Von Burg R; Penney DP; Passalacqua W; Sutherland RM
    Br J Cancer; 1980 Apr; 41(4):523-8. PubMed ID: 7387850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The brain stem auditory evoked response as a tool in neuro-behavioral toxicology and medicine.
    Rebert CS
    Prog Brain Res; 1980; 54():458-62. PubMed ID: 7220952
    [No Abstract]   [Full Text] [Related]  

  • 37. Energy and misonidazole toxicity: the effects of 5-thio-D-glucose.
    Skov KA; Korbelik M; Palcic B; Skarsgard LD
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):697-700. PubMed ID: 7107401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of cytotoxic drugs with or without misonidazole on leucopenia in three strains of mice.
    McNally NJ; Stephens TC; Twentyman PR; Hinchliffe M; Peacock JH; Spooner D
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):659-62. PubMed ID: 7107394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Misonidazole neurotoxicity in rats: Part I. Evaluation of misonidazole neurotoxicity in rats by analysis of brain stem auditory and cortical evoked potentials.
    Edwards MS; Gordon DG; Levin VA; Phillips TL
    J Neurooncol; 1984; 2(2):91-4. PubMed ID: 6481428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The neurotoxicity of misonidazole: potential modifying role of dexamethasone.
    Workman P
    Br J Radiol; 1980 Jul; 53(631):736. PubMed ID: 7426903
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.